AGP Picks
View all

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on October 12, 2026

FCC/FCC compatibility enables Al10Cr28Co28Ni34/Ag lubricity, wear & cavitation resistance in aviation kerosene
NexLife Announces October 2026 GLP-1 Price Index on Online Prices of Compounded Tirzepatide and Semaglutide
Teva to Host R&D Day on Wednesday, November 11 in New York City
Biomea Fusion to Announce Phase I Results for BMF-650, Its Next-Generation Oral Small-Molecule GLP-1 Receptor Agonist
Bitdeer AI Expands Malaysia Campus with New 60MW A103 Facility, Closing in on Up-to-350MW Global Capacity Target
Broken Tooth in West Hollywood? Same-Day Extraction and Implant Placement May Be an Option for Qualifying Patients
TeleSpecialists Reaches 2 Million Patient Encounters, Achieving Second Million in Less Than One-Third the Time
Cell by Cell: New Machine-Learning-Based Method Reveals What Can Make Bacteria Dangerous
Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers
Top Microscope Manufacturer Advancing Precision Imaging and Laboratory Solutions
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026
Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026
PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026
Nurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results
Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update
ArriVent Announces First Patient Dosed with Novel Tetravalent MUC16/NaPi2b Dual Target ADC, ARR-002
NewHydrogen to Release a Special Report on October 19, 2026
Syndax Announces Topline Results from MAXPIRe Phase 2 Trial of Axatilimab in Idiopathic Pulmonary Fibrosis

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.